ALTEOGEN Inc. (196170.KQ)

KRW 286500.0

(-3.54%)

Long Term Debt Summary of ALTEOGEN Inc.

ALTEOGEN Inc.'s latest annual long term debt in 2023 was 1.24 Billion KRW , up 81.71% from previous year.
ALTEOGEN Inc.'s latest quarterly long term debt in 2024 Q2 was 6.32 Billion KRW , up 406.63% from previous quarter.
ALTEOGEN Inc. reported annual long term debt of 687.5 Million KRW in 2022, down -26.67% from previous year.
ALTEOGEN Inc. reported annual long term debt of 937.5 Million KRW in 2021, up 36.36% from previous year.
ALTEOGEN Inc. reported quarterly long term debt of 1.24 Billion KRW for 2024 Q1, up 0.0% from previous quarter.
ALTEOGEN Inc. reported quarterly long term debt of 1.24 Billion KRW for 2023 FY, up 81.71% from previous quarter.

Annual Long Term Debt Chart of ALTEOGEN Inc. (2023 - 2012)

Historical Annual Long Term Debt of ALTEOGEN Inc. (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	1.24 Billion KRW	81.71%
2022	687.5 Million KRW	-26.67%
2021	937.5 Million KRW	36.36%
2020	687.5 Million KRW	-31.25%
2019	1 Billion KRW	-33.33%
2018	1.5 Billion KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%
2014	- KRW	-100.0%
2013	1.14 Billion KRW	2.29%
2012	1.11 Billion KRW	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	6.32 Billion KRW	406.63%
2024 Q1	1.24 Billion KRW	0.0%
2023 FY	1.24 Billion KRW	81.71%
2023 Q4	1.24 Billion KRW	-25.38%
2023 Q1	2.33 Billion KRW	239.64%
2023 Q3	1.67 Billion KRW	-3.6%
2023 Q2	1.73 Billion KRW	-25.62%
2022 Q4	687.5 Million KRW	-8.33%
2022 Q2	812.5 Million KRW	-7.14%
2022 FY	687.5 Million KRW	-26.67%
2022 Q1	875 Million KRW	-6.67%
2022 Q3	750 Million KRW	-7.69%
2021 Q4	937.5 Million KRW	87.5%
2021 FY	937.5 Million KRW	36.36%
2021 Q2	562.5 Million KRW	-10.0%
2021 Q3	500 Million KRW	-11.11%
2021 Q1	625 Million KRW	-19.06%
2020 Q4	772.15 Million KRW	-30.47%
2020 Q3	1.11 Billion KRW	4.82%
2020 Q1	1.04 Billion KRW	-1.05%
2020 Q2	1.05 Billion KRW	1.8%
2020 FY	687.5 Million KRW	-31.25%
2019 Q2	2.81 Billion KRW	87.49%
2019 Q3	1.29 Billion KRW	-54.1%
2019 FY	1 Billion KRW	-33.33%
2019 Q1	1.5 Billion KRW	0.0%
2019 Q4	1.05 Billion KRW	-18.51%
2018 Q1	- KRW	0.0%
2018 Q4	1.5 Billion KRW	0.0%
2018 FY	1.5 Billion KRW	0.0%
2018 Q2	- KRW	0.0%
2018 Q3	1.5 Billion KRW	0.0%
2017 Q1	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q3	- KRW	0.0%
2017 Q2	- KRW	0.0%
2017 Q4	- KRW	0.0%
2016 Q2	- KRW	0.0%
2016 Q3	- KRW	0.0%
2016 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2016 Q1	- KRW	0.0%
2015 FY	- KRW	0.0%
2015 Q2	- KRW	0.0%
2015 Q1	- KRW	0.0%
2015 Q3	- KRW	0.0%
2015 Q4	- KRW	0.0%
2014 Q4	- KRW	0.0%
2014 FY	- KRW	-100.0%
2014 Q2	1.2 Billion KRW	0.0%
2014 Q1	- KRW	-100.0%
2013 Q3	1.14 Billion KRW	0.0%
2013 Q1	- KRW	0.0%
2013 Q4	1.14 Billion KRW	0.0%
2013 FY	1.14 Billion KRW	2.29%
2012 FY	1.11 Billion KRW	0.0%

Peer Long Term Debt Comparison of ALTEOGEN Inc.

Name	Long Term Debt	Long Term Debt Difference
HLB Co., Ltd.	17.93 Billion KRW	93.034%
iNtRON Biotechnology, Inc.	258.29 Million KRW	-383.655%
BINEX Co., Ltd.	5.57 Billion KRW	77.605%
Bioneer Corporation	12.5 Billion KRW	90.006%
Anterogen.Co.,Ltd.	- KRW	-Infinity%
MEDIPOST Co., Ltd.	6.99 Billion KRW	82.141%
CrystalGenomics, Inc.	29.88 Billion USD	95.82%
Helixmith Co., Ltd	151.68 Million KRW	-723.613%
Chabiotech Co.,Ltd.	95.06 Billion KRW	98.686%
Medy-Tox Inc.	1.22 Billion KRW	-1.91%
Peptron, Inc.	4.5 Billion KRW	72.239%
Amicogen, Inc.	70.65 Billion KRW	98.232%
Genexine, Inc.	22.68 Billion KRW	94.492%
HLB Therapeutics Co.,Ltd.	1.84 Billion KRW	32.113%
LegoChem Biosciences, Inc.	528.37 Million KRW	-136.435%
PharmaResearch Co., Ltd.	970.71 Million KRW	-28.694%
SillaJen, Inc.	8.13 Billion KRW	84.645%
JETEMA, Co., Ltd.	60 Billion KRW	97.918%
OliX Pharmaceuticals,Inc	35.36 Billion KRW	96.467%
Genomictree Inc.	97.51 Million KRW	-1181.083%
MedPacto, Inc.	1.68 Billion KRW	25.946%
D&D Pharmatech	5.12 Billion KRW	75.603%
EASY BIO,Inc.	30 Billion KRW	95.836%
GI Innovation, Inc.	2.9 Billion KRW	56.982%